1. |
Guidelines for the management of acromegaly |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
2. |
Cardiovascular interventions can reduce death, disability, says WHO |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
3. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
4. |
Escitalopram good value for depression in Finland |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
5. |
Value of budesonide demonstrated in multinational study |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 6-6
Cameron Johnston,
Preview
|
|
摘要:
Inhaled corticosteroids are known to cost significantly more than β2-agonists when used to treat asthma, and this has been one of the reasons, among others, that they have not been used as widely as they could be. However, a large international study has demonstrated that the higher cost of budesonide, one of the older inhaled corticosteroids on the market today, can be substantially offset by fewer hospital admissions and emergency-department (ED) visits, with patients experiencing more symptom-free days and less time lost from school or work. In some countries, where the standard of living and the national average income are relatively high, using budesonide can actually represent a net saving to the national economy, since time lost from school or work can have a substantial effect on a country's gross national product. In two presentations at the 12th Annual Meeting of the European Respiratory Society, held in Stockholm, Sweden, in September, physicians from Belgium, Sweden, the UK and the US discussed the Inhaled Steroid as Regular Treatment (START) study.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
6. |
Hib vaccination programme'highly cost-beneficial'in the US |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
8. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
9. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|
10. |
Risperidone for behavioural and psychological symptoms of dementia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1361,
2002,
Page 11-13
Raewyn Poole,
Preview
|
|
摘要:
The atypical antipsychotic risperidone ['Risperdal'] improves behavioural and psychological symptoms of dementia (BPSD) in elderly patients, according to several studies presented at the XII World Congress of Psychiatry [Yokohama, Japan; August 2002]. Treatment with low doses of risperidone was effective and well tolerated in patients in both the outpatient and hospital settings, including those patients switching from other antipsychotics. Furthermore, efficacy was demonstrated in patients with mixed or vascular dementia in addition to those with Alzheimer's disease.
ISSN:1173-8324
出版商:ADIS
年代:2002
数据来源: ADIS
|